Jens Moreth

Characterisation of different amyloid-ß aggregates in Alzheimer's disease

Jens Moreth, 2012 .

Restoring long-term potentiation impaired by amyloid-beta oligomers: Comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists

H. Rosenbrock, L. Kussmaul, G. Rast, 2013, Brain Research Bulletin.

Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review

Katharina Schindowski, K. Schindowski, Jens Moreth, 2013, Front. Aging Neurosci..

Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?

K. Schindowski, Chrystelle Mavoungou, Jens Moreth, 2013, Immunity & Ageing.

Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?

K. Schindowski, Chrystelle Mavoungou, Jens Moreth, 2013, Immunity & Ageing.

Globular and protofibrillar aβ aggregates impair neurotransmission by different mechanisms.

C. V. von Arnim, B. Hengerer, C. Schnack, 2013, Biochemistry.